Lipolysis

In brief: Lipolysis is a non-invasive treatment that breaks down localized fat deposits without surgery. The main methods are injection lipolysis (deoxycholic acid), cryolipolysis, laser lipolysis and focused ultrasound. It is indicated for localized deposits that do not respond to diet, such as submental fat, the abdomen and the hips; it is NOT intended for significant obesity (BMI > 30). Results become visible at 6-8 weeks, with maximum effect at 12-16 weeks. 1-3 sessions are sufficient.

Definition

Lipolysis (from the Greek lipo-: fat, and -lysis: breakdown) in its general sense is the process by which adipocytes (fat cells) are broken down and their contents (triglycerides) released into systemic metabolism. In the context of medical aesthetics, non-invasive lipolysis is the group of treatments that target and break down localized subcutaneous fat deposits using externally applied chemical or physical mechanisms. Liposuction (lipoaspiration) — the surgical aspiration of fat with a cannula — should not be confused with this; lipolysis is not considered surgery, does not require anesthesia and involves minimal downtime.

Lipolysis is performed using four main modalities: (1) Injection lipolysis — deoxycholic acid (DCA) and phosphatidylcholine (PC)-based solutions; FDA-approved Kybella (DCA, submental fat); (2) Cryolipolysis — selective adipocyte apoptosis through controlled cooling (-11°C to +5°C); FDA-cleared CoolSculpting; (3) Laser lipolysis — hyperthermic adipocyte necrosis with a 1060 nm diode (SculpSure) or 1064 nm Nd:YAG; (4) Focused ultrasound — local hyperthermia with high-intensity focused ultrasound (HIFU) (UltraShape, Liposonix) and mechanical cavitation (cavitation devices).

The basis of chemical lipolysis: deoxycholic acid (a bile acid metabolite, FDA-approved in 2015) disrupts the adipocyte cell membrane through an emulsifying action; cell lysis → inflammatory response → macrophage clearance → lymphatic drainage → gradual softening (6-12 weeks). The physical modalities (cryo, laser, ultrasound) trigger adipocyte apoptosis/necrosis through selective thermal/mechanical injury; the clearance mechanism is the same.

The difference from liposuction is critical: liposuction aspirates a large volume of fat in a single session (under anesthesia, with 1-2 weeks of downtime and a surgical risk profile), whereas lipolysis involves small to moderate volumes, multiple sessions, no anesthesia and minimal downtime. Lipolysis candidate: BMI in the normal to overweight range (25-30) with localized "spot" fat; liposuction candidate: a larger volume, with a change in body contour as the goal.

How It Is Applied

The lipolysis modalities involve different treatment protocols:

1. Injection Lipolysis (Deoxycholic Acid — DCA)

1. Consultation: The physician assesses BMI, measures the target area, takes photographic documentation and evaluates skin elasticity (risk of laxity after contouring) and previous procedure history (previous liposuction, fillers).
2. Preparation: The submental or body area is cleansed with chlorhexidine. The target fat area is marked (usually a grid pattern at 1 cm intervals, a total of 20-30 points submentally and 50-100 points for the body).
3. Topical anesthesia: EMLA cream for 30-40 minutes or pre-cooling with ice.
4. Injection: Using a fine needle, small amounts of DCA (Kybella) at multiple points into the subcutaneous fat layer — the volume is determined individually by the physician based on anatomy and product labelling — (5-10 mm depth); NOT into the skin or muscle surfaces. The total volume per submental session is set by the physician.
5. Duration and Interval: A session takes 15-20 minutes. Interval 4-6 weeks. A total of 2-6 sessions (depending on clinical response).

2. Cryolipolysis (Cooling)

1. An applicator specific to the target area (vacuum-suction based). Cooling from -11°C to +5°C (device-specific).
2. Duration 35-60 minutes per applicator; 1-3 applicators per session (depending on the size of the area).
3. Post-treatment massage (manual, 2-5 minutes) — important as a trigger of adipocyte fragmentation and apoptosis.
4. Interval 8-12 weeks. A total of 1-3 sessions.

3. Laser Lipolysis (1060 nm Diode — SculpSure)

1. Adipogenic thermal targeting (target temperature 43-45°C) for 25 minutes per applicator.
2. Integrated cooling system (the skin surface is protected).
3. Interval 6-12 weeks. A total of 1-3 sessions.

4. Focused HIFU / Ultrasound (UltraShape, Liposonix)

1. High-intensity focused ultrasound — 0.95-1.5 J/cm² mechanical cavitation / thermal coagulation.
2. Session 45-60 minutes.
3. Interval 4-6 weeks. A total of 2-3 sessions.

Indications

Lipolysis is used in the following clinical situations:

Primary Indications

• Submental Fat (Double Chin) — ICD-10 E66.9: The most classic indication; Kybella FDA-approved in 2015. A "submental fullness" score (1-4) similar to the Norwood scale.
• Abdominal Area (Abdomen): Localized fat in the lower abdomen (below the navel) and the flanks ("love handles"). In patients with BMI < 30.
• Hip–Trochanteric Area (Bra Roll, Saddle Bags): The fat fold along the bra line; lateral hip prominence.
• Inner Thigh: Fullness of the inner knee area and upper inner thigh.
• Outer Thigh: "Saddle bag" contouring.
• Upper Arm / Axilla: Bra-line bulge.
• Back: Fat rolls of the upper and middle back.

Secondary Indications

• Contour Correction After Liposuction: Small residual asymmetric deposits.
• General Body Contouring "Maintenance": Spot targeting alongside a diet and exercise program.
• Mild Gynecomastia (Male Breast Fat, N62): Only fatty pseudogynecomastia, in the absence of a glandular component.

Contraindications

Absolute Contraindications

• Pregnancy and Breastfeeding: There are no fetal/infant safety data for DCA or the other modalities.
• Significant Obesity (BMI > 30): Lipolysis is a "spot reduction" treatment; it does not produce systemic fat loss. A bariatric approach or medical weight management takes priority.
• Active Local Infection or Skin Lesion: At the injection site or in the applicator area.
• Cryoglobulinemia, Cold Agglutinin Disease, Paroxysmal Cold Hemoglobinuria: Cryolipolysis is absolutely contraindicated (risk of vaso-occlusion).
• Severe Raynaud's Phenomenon: Caution with cryolipolysis; an alternative modality is preferred.
• Known DCA Allergy: An alternative modality to injection lipolysis.

Relative Contraindications

• Anticoagulant Use: Risk of ecchymosis; more pronounced ecchymosis is to be expected with injection lipolysis.
• Tendency to Hypertrophic Scarring / Keloids: At the injection sites.
• Body-Image Anxiety / Body Dysmorphia: Managing expectations is critical; a psychological consultation may be recommended.
• Marked Skin Laxity (Major Skin Laxity): Laxity may increase after fat loss; RF/HIFU/surgical skin tightening are alternatives.
• Hernia (When Treating the Abdomen): Umbilical/ventral hernia should be checked for.

Duration of Effect and Recovery

Lipolysis Modalities — Timeline of Effect and Recovery

Modality	First Visible Result	Maximum Effect	Number of Sessions	Downtime
Injection (DCA)	4-6 weeks	12-16 weeks	2-6	Swelling 1-2 weeks
Cryolipolysis	6-8 weeks	12-16 weeks	1-3	Minimal — localized redness 1-2 days
Laser Lipolysis	6 weeks	12 weeks	1-3	Minimal — mild erythema
HIFU/Ultrasound	4-6 weeks	12-16 weeks	2-3	Minimal

Expected Volume Reduction: A 20-25% reduction in subcutaneous fat in the treated area after a single session; a cumulative target of 40-50% with multiple sessions. This statistic applies only to the treated area — it does NOT produce systemic weight loss.

Durability of Results: Once adipocytes have been broken down they do not come back (apoptotic clearance). However, new fat storage is possible through hypertrophy of the remaining adipocytes if lifestyle (diet, exercise) deteriorates. With a stable diet and exercise routine, the result is long-lasting.

Risks and Side Effects

Common (Mild, Temporary)

• Swelling (Edema): Marked after injection lipolysis (1-2 weeks submentally, 3-5 days on the body). The effect that most requires patient information.
• Ecchymosis / Hematoma: At the injection sites, 5-10 days.
• Tenderness, Pain: 24-72 hours; gentle, non-aggressive non-steroidal analgesia for relief.
• Redness, Firmness: A feeling of firmness in the treated area for 1-2 weeks; numbness for 1-3 weeks after cryolipolysis.
• Itching: During the inflammatory response phase after DCA.

Rare

• Temporary Nerve Irritation: The marginal mandibular nerve in submental treatment (resembling a smile paralysis); in 4-5% of patients, resolving within 4-8 weeks.
• Difficulty Swallowing (Dysphagia): 2% after submental DCA injection; resolves within 1-2 weeks.
• Contour Irregularity: An asymmetric injection pattern; corrected with a touch-up.
• Paradoxical Adipose Hyperplasia (Cryolipolysis): Very rare (0.0051%), an increase in fat in the treated area; the lateral abdomen in male patients is at higher risk. Liposuction may be needed for correction.
• Skin Color Change (PIH): At the injection sites in patients with darker skin.

Very Rare / Serious

• Local necrosis (incorrect treatment technique)
• Allergy / anaphylaxis (isolated case reports for DCA)
• Permanent nerve damage (in the absence of adequate anatomical knowledge)

Transparency note: The "no pain, no result" principle does not apply to lipolysis — a degree of inflammatory response is necessary for a result to form, but aggressive treatment can lead to contour irregularity. Physician experience and adherence to protocol maximize safety.

Comparison: Lipolysis vs. Liposuction vs. Diet + Exercise

This page does not quote fixed prices. The fee is clarified after the physician's examination, based on the product or device, the treatment area, the amount required, the plan and the assessment of medical suitability.

Clinical decision pathway: BMI 22-28 + localized spot fat → non-invasive lipolysis; BMI 28-32 + large-volume goal → consider liposuction; BMI > 32 → medical weight management takes priority. Diet + exercise is always a necessary foundation.

Alternatives and Combination Treatments

Alternatives

• Liposuction (Surgical): Large volume; a definitive result in a single session.
• Renuvion (Plasma Skin Tightening): For skin laxity after fat loss.
• Medical Weight Management: GLP-1 agonists (semaglutide, tirzepatide), endocrinology consultation.
• Bariatric Surgery: BMI > 35 + comorbidity.

Combination Treatments

• Lipolysis + RF Skin Tightening (Morpheus8, Thermage): Combined fat reduction and skin tightening. Particularly in submental treatment for patients over 40.
• Lipolysis + HIFU (Ultherapy): A complete skin-and-tissue contouring package.
• Lipolysis + Mesotherapy (Lipolytic Cocktail): Combined treatment of cellulite and localized fat.
• Lipolysis + Profhilo / Skinbooster: Supporting skin quality after fat reduction.
• Lipolysis + Diet/Exercise Program: The standard gold combination; metabolic support.

Scientific Evidence

1. FDA Pivotal Trials (Deoxycholic Acid — Kybella): Humphrey et al. (2016, Dermatol Surg), pooled REFINE-1/2 phase III, n=1022 patients with submental fat. 2-6 sessions of DCA vs. placebo. Result: ≥1 grade improvement in 68% of patients (Clinician's Reported Submental Fat Rating Scale + Magnetic Resonance Imaging-verified volume reduction); placebo 19%. NNT = 2.

2. Cryolipolysis Meta-Analysis: Ingargiola et al. (2015, Plast Reconstr Surg), 19 studies, n=2730. Mean reduction in fat thickness: 14.7-28.5% (ultrasonography). Patient satisfaction score: 73%. Paradoxical adipose hyperplasia: 0.0051%.

3. SculpSure Laser Lipolysis RCT: Decorato et al. (2017, Lasers Surg Med), n=99, single abdominal treatment session, ultrasonography at 12 weeks. Reduction in fat thickness 24%.

4. HIFU UltraShape Trial: Hotta et al. (2016, J Cosmet Dermatol), n=87 abdomen, 3 sessions. Mean circumference reduction 2.5 cm; 18% reduction in fat thickness on ultrasonography.

5. Mechanism Study — DCA Adipocyte Lysis: Thuangtong et al. (2010, Dermatol Surg), in vitro adipocyte culture. DCA emulsifies the cell membrane, followed by lysis and then macrophage phagocytosis; complete clearance in 8-12 weeks.

The Turkish Market and Clinical Practice

In Turkey, lipolysis is widely performed in dermatology and medical aesthetics clinics. Average price ranges in Turkey for 2026:

The Ataşehir, Beşiktaş and Nişantaşı districts of Istanbul are in the premium price range. Prices in Anatolian provinces are 30-40% lower. It is not covered by SGK, Turkey's public health insurance (aesthetic indication). Lipolysis packages are popular in the international medical-tourism segment (particularly among patients from Germany and the United Kingdom).

Related Terms

Hyaluronic Acid, Microneedling RF, Morpheus8, HIFU, Thermage FLX, Post-Procedure Care, Swelling (Edema), Hematoma

Frequently Asked Questions

1. Is lipolysis the same as liposuction?

   No. Liposuction is a surgical procedure — the physical aspiration of fat with a cannula. Lipolysis is non-surgical; it breaks down adipocytes using injection, cooling, laser or ultrasound. Lipolysis does not require anesthesia and involves minimal downtime; liposuction removes a large volume but carries surgical risk.

2. Does lipolysis make you lose weight?

   No. Lipolysis does not produce a systemic change in weight — it only reduces fat in the localized area treated ("spot reduction"). General weight loss requires diet + exercise + medical weight management.

3. Are the results permanent?

   Yes, adipocytes that have been broken down do not come back (apoptosis). However, if lifestyle deteriorates (a high-calorie diet, a sedentary lifestyle), the remaining adipocytes undergo hypertrophy and fat storage becomes possible again. With a diet and exercise routine, the result is long-lasting.

4. Is lipolysis painful?

   It depends on the modality. Injection lipolysis involves a stinging sensation during treatment + tenderness and swelling for 24-72 hours afterwards. Cryolipolysis: intense cold in the first few minutes, followed by numbness. Laser and HIFU: a mild sensation of warmth. It is generally well tolerated; topical anesthesia provides support.

5. Which age group is it suitable for?

   Any adult over 18 is suitable, when BMI is < 30 and the target area "does not respond to diet". Over the age of 50, skin elasticity may be reduced, so an RF/HIFU combination is recommended for laxity after fat loss.

6. Does lipolysis treat cellulite?

   Cellulite has a different pathophysiology from localized fat (fibrotic septa + dermal structure). Lipolysis alone is of limited value for cellulite; a combination of mesotherapy, acoustic wave therapy and RF microneedling is more effective.

7. Can lipolysis be done during pregnancy?

   No. All lipolysis modalities are contraindicated during pregnancy and breastfeeding (there are no fetal/infant safety data). Treatment can be started 6-12 months after giving birth.

Dr. Hamza Gemici's Commentary

"In assessing localized fat, the diagnosis, medical suitability and a realistic goal must be clarified first. Injection, cryolipolysis, laser and HIFU are not the same method; a fixed session or results schedule cannot be given until the exact model of the device, including HIFU, its intended use and the individual's specific risks have been verified. Non-surgical methods do not produce systemic weight loss and are not equivalent to liposuction."

— Dr. Hamza Gemici

Sources and References

1. Humphrey S, et al. "ATX-101 (deoxycholic acid injection) for reduction of submental fat: pooled phase III analysis."
   Dermatol Surg, 2016
   URL: https://pubmed.ncbi.nlm.nih.gov/27340855/
2. Ingargiola MJ, et al. "Cryolipolysis for fat reduction and body contouring: systematic review."
   Plast Reconstr Surg, 2015
   URL: https://pubmed.ncbi.nlm.nih.gov/26313829/
3. Decorato JW, et al. "Subcutaneous adipose tissue response to a non-invasive hyperthermic treatment using a 1060-nm laser."
   Lasers Surg Med, 2017
   URL: https://pubmed.ncbi.nlm.nih.gov/28370160/
4. Hotta TA, et al. "Focused ultrasound treatment for abdominal contouring."
   J Cosmet Dermatol, 2016
   URL: https://pubmed.ncbi.nlm.nih.gov/27416541/
5. Thuangtong R, et al. "Mechanism of deoxycholic acid action on adipocyte lysis."
   Dermatol Surg, 2010
   URL: https://pubmed.ncbi.nlm.nih.gov/21070456/
6. FDA Kybella (deoxycholic acid) — Prescribing Information
   URL: https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206333lbl.pdf
   Year: 2015 (initial approval)

Last updated: 20 May 2026 · Medical editor: Dr. Hamza Gemici